TACSTD2 and hepatocellular carcinoma: Furthermore, in primary HCC tumor tissue we found no alteration in the expression of EMT markers compared to the surrounding nontumorous tissue, in spite of the significant reduction of HCV RNA and downregulation of TACSTD2 (S3 Fig).